DCGI approves Phase II/III clinical trial of COVAXIN in the age group of 2 to 18 Years
M/s Bharat Biotech International Ltd., Hyderabad (BBIL) had proposed to carry out a Phase- II/III clinical trial of Covaxin in the age...
10 views0 comments
India: DCGI approves anti-COVID drug developed by DRDO for emergency use
An anti-COVID-19 therapeutic application of the drug 2-deoxy-D-glucose (2-DG) has been developed by the Institute of Nuclear Medicine and...
8 views0 comments